Cell
Volume 181, Issue 4, 14 May 2020, Pages 865-876.e12
ArticleDevelopment of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
open access
Graphical Abstract
Keywords
CRISPR
Cas13
COVID-19
SARS-CoV-2
2019-nCoV
RdRP
nucleocapsid
IAV
influenza
antiviral
Cited by (0)
© 2020 Elsevier Inc.